Lifecore Biomedical, Inc. (LFCR)
USD 6.94
(-7.1%)
USD 6.94
(-7.1%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -217 Thousand | -34.45 Million | -24.39 Million | 15.01 Million | -17.04 Million | 16.02 Million |
| Net Income | 9.33 Million | -102.19 Million | -97.23 Million | -32.66 Million | -38.19 Million | 411 Thousand |
| Depreciation & Amortization | 8 Million | 13.5 Million | 17.78 Million | 19.86 Million | 18.83 Million | 15.23 Million |
| Deferred income taxes | 163 Thousand | 351 Thousand | -6.88 Million | -7.89 Million | -5.44 Million | 910 Thousand |
| Stock-based compensation | 6.2 Million | 3612.00 | 2642.00 | 3305.00 | 2375.00 | 3.56 Million |
| Change in working capital | -3.84 Million | 22.07 Million | -6.69 Million | 8.89 Million | -27.66 Million | -1.17 Million |
| Other non-cash items | 10.34 Million | 28.18 Million | 66.02 Million | 23.45 Million | 32.99 Million | -2.91 Million |
| Investing Cash Flow | -17.92 Million | -4.15 Million | 81.76 Million | -10.85 Million | -23.88 Million | -96.79 Million |
| Investments in PPE | -17.92 Million | -20.76 Million | -28.13 Million | -23.76 Million | -26.68 Million | -44.73 Million |
| Acquisitions | - | 16.61 Million | 63.66 Million | 12.91 Million | 2.43 Million | -59.87 Million |
| Investment purchases | - | - | - | - | - | 264 Thousand |
| Sales/Maturities of investments | - | - | 45.1 Million | - | - | 7 Million |
| Other Investing Activities | - | 16.67 Million | 1.14 Million | 12.91 Million | 364 Thousand | 545 Thousand |
| Financing Cash Flow | 7.5 Million | 39.7 Million | -57.02 Million | -3.41 Million | 40.01 Million | 79.02 Million |
| Debt repayment | -1.93 Million | -2.93 Million | -130.52 Million | -262.53 Million | -105.02 Million | -39.09 Million |
| Dividends payments | -3.07 Million | - | - | - | - | - |
| Common Stock Repurchased | -152 Thousand | -274 Thousand | -789 Thousand | -405 Thousand | -212 Thousand | -700 Thousand |
| Common Stock Issuance | 724 Thousand | 42.9 Million | - | - | 30 Thousand | 327 Thousand |
| Other Financing Activities | 4.84 Million | -274 Thousand | 74.29 Million | 259.51 Million | 145.43 Million | 119.19 Million |
| Accounts receivables | -2.39 Million | 12.19 Million | -6.29 Million | 5.77 Million | -6.64 Million | -8.86 Million |
| Accounts payables | -6.67 Million | 16.08 Million | 9.34 Million | -5.98 Million | -1.24 Million | 19.11 Million |
| Inventory | 862 Thousand | -13.82 Million | -6.08 Million | -3.35 Million | -12.17 Million | -10.92 Million |
| Other working capital | 4.36 Million | 7.61 Million | -3.66 Million | 12.44 Million | -7.59 Million | -506 Thousand |
| Cash at beginning of period | 19.09 Million | 1.64 Million | 1.29 Million | 553 Thousand | 1.46 Million | 3.21 Million |
| Cash at end of period | 8.46 Million | 19.09 Million | 1.64 Million | 1.29 Million | 553 Thousand | 1.46 Million |
| Capital Expenditure | -17.92 Million | -20.76 Million | -28.13 Million | -23.76 Million | -26.68 Million | -44.73 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -10.62 Million | 17.44 Million | 348 Thousand | 742 Thousand | -912 Thousand | -1.75 Million |
| Free Cash Flow | -18.13 Million | -55.22 Million | -52.53 Million | -8.75 Million | -43.72 Million | -28.71 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9.33 Million | -7.08 Million | 14.78 Million | 14.24 Million | -12.61 Million | -102.19 Million |
| Depreciation & Amortization | 8 Million | 1.39 Million | 4.43 Million | 2.2 Million | 2.16 Million | 13.5 Million |
| Deferred income taxes | 163 Thousand | -64 Thousand | 191 Thousand | -40 Thousand | 76 Thousand | 351 Thousand |
| Stock-based compensation | 6.2 Million | 1.59 Million | 1.49 Million | 1.57 Million | 1.53 Million | 3612.00 |
| Change in working capital | -3.84 Million | 4.55 Million | -4.78 Million | 586 Thousand | -4.2 Million | 22.07 Million |
| Other non-cash items | 10.34 Million | 15.01 Million | -7.54 Million | -8.16 Million | 13.23 Million | 28.18 Million |
| Investing Cash Flow | -17.92 Million | -2.63 Million | -6.25 Million | -3.97 Million | -5.05 Million | -4.15 Million |
| Investments in PPE | -17.92 Million | -2.63 Million | -6.25 Million | -3.97 Million | -5.05 Million | -20.76 Million |
| Acquisitions | - | - | - | - | - | 16.61 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 16.67 Million |
| Financing Cash Flow | 7.5 Million | -738 Thousand | 7.76 Million | -2.44 Million | 2.93 Million | 39.7 Million |
| Debt repayment | -1.93 Million | -685 Thousand | -2.8 Million | -2.43 Million | -2.25 Million | -2.93 Million |
| Dividends payments | -3.07 Million | - | - | - | -748 Thousand | - |
| Common Stock Repurchased | - | - | - | - | - | -274 Thousand |
| Common Stock Issuance | 724 Thousand | - | - | - | 724 Thousand | 42.9 Million |
| Other Financing Activities | 4.84 Million | -53 Thousand | 4.95 Million | -12 Thousand | -45 Thousand | -274 Thousand |
| Accounts receivables | -2.39 Million | 106 Thousand | -1.28 Million | -3.59 Million | 2.38 Million | 12.19 Million |
| Accounts payables | -6.67 Million | -2.05 Million | -356 Thousand | -59 Thousand | -4.2 Million | 16.08 Million |
| Inventory | 862 Thousand | -309 Thousand | 1.77 Million | 244 Thousand | -849 Thousand | -13.82 Million |
| Other working capital | 4.36 Million | 6.81 Million | -4.91 Million | 3.99 Million | -1.53 Million | 7.61 Million |
| Cash at beginning of period | 19.09 Million | 3.07 Million | 3.22 Million | 8.64 Million | 19.09 Million | 1.64 Million |
| Cash at end of period | 8.46 Million | 8.46 Million | 3.07 Million | 3.22 Million | 8.64 Million | 19.09 Million |
| Capital Expenditure | -17.92 Million | -2.63 Million | -6.25 Million | -3.97 Million | -5.05 Million | -20.76 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -10.62 Million | 5.38 Million | -148 Thousand | -5.42 Million | -10.44 Million | 17.44 Million |
| Free Cash Flow | -18.13 Million | 6.12 Million | -7.9 Million | -2.97 Million | -13.38 Million | -55.22 Million |
JSWHL
0I1B
TELO
SBXC
600470
FI